| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 2e-06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 9e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |